Jason Duncan

Insider Reports History

Location
Watertown, MA
Signature
/s/ Michael Milligan, as Attorney-in-Fact for Jason Duncan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Duncan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Title: Chief Legal and Administrative Officer Stock Option (Right to Buy) 750,000 08 Jan 2026 Direct
ALBIREO PHARMA, INC. Chief Legal Officer and GC Common Stock 0 $43.80 02 Mar 2023 Direct
ALBIREO PHARMA, INC. Chief Legal Officer and GC Restricted Stock Units 0 02 Mar 2023 Direct
ALBIREO PHARMA, INC. Chief Legal Officer and GC Stock Option (right to buy) 0 02 Mar 2023 Direct

Insider Reports Filed by Jason Duncan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NMRA Neumora Therapeutics, Inc. 08 Jan 2026 1 $0 4 Title: Chief Legal and Administrative Officer 09 Jan 2026, 16:18
NMRA Neumora Therapeutics, Inc. 28 May 2025 4 $0 4 Title: Chief Legal and Administrative Officer 30 May 2025, 18:30
NMRA Neumora Therapeutics, Inc. 13 Feb 2025 3 $0 4 Title: Chief Legal and Administrative Officer 18 Feb 2025, 16:30
NMRA Neumora Therapeutics, Inc. 11 Dec 2023 1 $0 4 Chief Legal Officer 12 Dec 2023, 18:16
NMRA Neumora Therapeutics, Inc. 11 Dec 2023 0 $0 3 Chief Legal Officer 12 Dec 2023, 18:15
/report/000120919123014741-duncan-jason-2023-03-02 ALBIREO PHARMA, INC. 02 Mar 2023 7 $0 4 Chief Legal Officer and GC 02 Mar 2023, 15:44
/report/000120919123004451-duncan-jason-2023-01-23 ALBIREO PHARMA, INC. 23 Jan 2023 1 -$9,986 4 Chief Legal Officer and GC 23 Jan 2023, 16:10
/report/000120919123005335-duncan-jason-2023-01-19-restatement ALBIREO PHARMA, INC. 19 Jan 2023 1 $0 4/A Chief Legal Officer and GC 27 Jan 2023, 16:26
/report/000120919123004223-duncan-jason-2023-01-19 ALBIREO PHARMA, INC. 19 Jan 2023 1 -$41,182 4 Chief Legal Officer and GC 20 Jan 2023, 15:05
/report/000120919122054490-duncan-jason-2022-10-24 ALBIREO PHARMA, INC. 24 Oct 2022 3 -$12,756 4 Chief Legal Officer and GC 25 Oct 2022, 16:00
/report/000120919122043100-duncan-jason-2022-07-22 ALBIREO PHARMA, INC. 22 Jul 2022 4 -$15,908 4 Chief Legal Officer and GC 25 Jul 2022, 16:12
/report/000120919122025522-duncan-jason-2022-04-22 ALBIREO PHARMA, INC. 22 Apr 2022 4 -$21,758 4 Chief Legal Officer and GC 25 Apr 2022, 16:38
/report/000120919122004809-duncan-jason-2022-01-24 ALBIREO PHARMA, INC. 24 Jan 2022 3 -$42,094 4 Chief Legal Officer and GC 25 Jan 2022, 15:39
/report/000120919122004060-duncan-jason-2022-01-18 ALBIREO PHARMA, INC. 18 Jan 2022 2 $0 4 Chief Legal Officer and GC 20 Jan 2022, 15:52
/report/000120919121061556-duncan-jason-2021-10-22 ALBIREO PHARMA, INC. 22 Oct 2021 2 -$9,079 4 Chief Legal Officer and GC 25 Oct 2021, 18:30
/report/000120919121048160-duncan-jason-2021-07-22 ALBIREO PHARMA, INC. 22 Jul 2021 2 -$10,081 4 Chief Legal Officer and GC 26 Jul 2021, 16:05
/report/000120919121043467-duncan-jason-2021-06-24 ALBIREO PHARMA, INC. 24 Jun 2021 8 -$195,621 4 Chief Legal Officer and GC 28 Jun 2021, 16:01